<DOC>
	<DOCNO>NCT00879164</DOCNO>
	<brief_summary>RATIONALE : A stellate ganglion nerve block may help relieve hot flash woman . PURPOSE : This clinical trial study well stellate ganglion nerve block work treat woman hot flash .</brief_summary>
	<brief_title>Stellate Ganglion Nerve Block Treating Women With Hot Flashes</brief_title>
	<detailed_description>OBJECTIVES : - To evaluate impact stellate ganglion blockade hot flash score . - To evaluate toxicity stellate ganglion blockade . OUTLINE : Patients undergo fluoroscopic-guided stellate ganglion blockade use bupivacaine hydrochloride week 1 . Patients complete hot flash diary daily symptom experience diary weekly week 1-7 Profile Mood States questionnaire week 1 7 . After completion study treatment , patient follow 2 month monthly 1 year .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Presence hot flash ≥ 1 month prior study registration Hot flash consider bothersome ( define occurrence ≥ 28 time per week sufficient severity make patient desire therapeutic intervention ) Use conventional hot flash treatment ( include new antidepressant gabapentin ) fail control hot flash ( defined patient ) PATIENT CHARACTERISTICS : ECOG performance status 01 Life expectancy ≥ 6 month Not childbearing potential , judged attend clinician Able complete questionnaire alone assistance No evidence active malignancy No von Willebrand 's disease bleeding disorder No allergy chlorhexidine bupivacaine PRIOR CONCURRENT THERAPY : More 4 week since prior concurrent antineoplastic chemotherapy , androgen , estrogen , progestational agent Tamoxifen , raloxifene , aromatase inhibitor allow provided patient constant dose ≥ 4 week continue receive medication study treatment More 10 day since prior concurrent anticoagulant ( e.g. , aspirin , clopidogrel , ticlopidine , warfarin ) Concurrent heparin flush venous catheter allow No concurrent use agent ( e.g. , megestrol acetate , soy , clonidine , Bellergal ) treat hot flash Vitamin E , gabapentin , antidepressant allow provided patient stable dose &gt; 30 day continue receive medication study treatment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>hot flash</keyword>
</DOC>